4.27 USD
↘ 0.24 (5.32%)AT CLOSE (11:59 AM EDT)
Perspective Therapeutics, Inc.
CATXAMEX • USD
4.29
↗ 0.02 (0.47%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
4.29
↗ 0.02 (0.47%)
Market: CLOSED
Open?$4.51
High?$4.71
Low?$4.16
Prev. Close?$4.51
Volume?1.4M
Avg. Volume?1.4M
VWAP?$4.35
Rel. Volume?1.00x
Bid / Ask
Bid?$4.27 × 400
Ask?$4.50 × 10.1K
Spread?$0.23
Midpoint?$4.39
Valuation & Ratios
Market Cap?514.2M
Shares Out?114.0M
Float?62.0M
Float %?83.4%
P/E Ratio?N/A
P/B Ratio?2.48
EPS?-$0.90
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.17Strong
Quick Ratio?5.17Strong
Cash Ratio?1.07Strong
Debt/Equity?0.01Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?2.48CHEAP▾
P/S?581.70HIGH▾
P/FCF?N/A▾
EV/EBITDA?-4.4CHEAP▾
EV/Sales?548.89HIGH▾
Returns & Efficiency
ROE?-49.8%WEAK▾
ROA?-38.6%WEAK▾
Cash Flow & Enterprise
FCF?$-95368000
Enterprise Value?$485.2M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Employees
166
Market Cap
514.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2003-12-29
Address
2401 ELLIOTT AVENUE
SEATTLE, WA 98121
Phone: 206-676-0900
SEATTLE, WA 98121
Phone: 206-676-0900